tiprankstipranks
Trending News
More News >
InMed Pharmaceuticals (INM)
NASDAQ:INM
US Market

InMed Pharmaceuticals (INM) Ratios

Compare
387 Followers

InMed Pharmaceuticals Ratios

INM's free cash flow for Q2 2026 was C$0.03. For the 2026 fiscal year, INM's free cash flow was decreased by C$ and operating cash flow was C$-2.59. See a summary of the company’s cash flow.
Ratios
TTM
Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio
5.94 6.99 4.41 5.66 2.89
Quick Ratio
-460.69 6.47 3.78 4.86 2.14
Cash Ratio
4.70 6.02 3.33 4.45 1.86
Solvency Ratio
-3.86 -2.61 -2.70 -3.65 -3.79
Operating Cash Flow Ratio
-4.38 -3.10 -3.54 -3.64 -3.65
Short-Term Operating Cash Flow Coverage
0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
C$ 9.86MC$ 14.61MC$ 6.07MC$ 9.32MC$ 7.58M
Leverage Ratios
Debt-to-Assets Ratio
0.05 0.05 0.08 0.03 0.06
Debt-to-Equity Ratio
0.06 0.06 0.10 0.03 0.09
Debt-to-Capital Ratio
0.05 0.05 0.09 0.03 0.08
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.17 1.16 1.28 1.17 1.41
Debt Service Coverage Ratio
-434.60 -19.45 0.00 0.00 0.00
Interest Coverage Ratio
-461.31 -21.22 0.00 0.00 0.00
Debt to Market Cap
0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
189.72 1.42 2.53 3.20 911.51
Net Debt to EBITDA
1.01 1.94 0.79 1.09 0.52
Profitability Margins
Gross Profit Margin
26.50%34.53%23.94%33.93%49.89%
EBIT Margin
-175.37%-157.62%-166.79%-202.60%-1265.95%
EBITDA Margin
-164.49%-146.80%-153.64%-188.19%-1218.98%
Operating Profit Margin
-174.60%-160.20%-176.92%-202.60%-1265.95%
Pretax Profit Margin
-171.58%-165.14%-166.79%-191.86%-1707.32%
Net Profit Margin
-171.58%-165.14%-166.94%-192.18%-1707.32%
Continuous Operations Profit Margin
-171.58%-165.14%-166.94%-192.18%-1707.32%
Net Income Per EBT
100.00%100.00%100.09%100.17%100.00%
EBT Per EBIT
98.27%103.08%94.27%94.70%134.86%
Return on Assets (ROA)
-59.02%-38.45%-64.92%-56.34%-112.99%
Return on Equity (ROE)
-62.93%-44.59%-83.37%-65.74%-159.16%
Return on Capital Employed (ROCE)
-69.22%-42.30%-82.57%-69.21%-113.16%
Return on Invested Capital (ROIC)
-66.42%-41.00%-79.99%-67.13%-108.52%
Return on Tangible Assets
0.60%-42.92%-76.45%-65.36%-135.31%
Earnings Yield
-284850.00%-257.32%-400.46%-350.16%-7060.61%
Efficiency Ratios
Receivables Turnover
21.05 7.80 13.03 15.88 9.61
Payables Turnover
16.98 6.42 5.58 5.02 0.36
Inventory Turnover
<0.01 2.47 2.81 1.69 0.17
Fixed Asset Turnover
<0.01 3.66 3.68 5.72 0.94
Asset Turnover
0.34 0.23 0.39 0.29 0.07
Working Capital Turnover Ratio
0.46 0.41 0.57 0.47 0.15
Cash Conversion Cycle
89.07K 137.62 92.53 166.20 1.18K
Days of Sales Outstanding
17.34 46.79 28.01 22.98 37.96
Days of Inventory Outstanding
89.08K 147.70 129.88 215.91 2.14K
Days of Payables Outstanding
21.50 56.88 65.36 72.69 1.00K
Operating Cycle
89.09K 194.50 157.89 238.89 2.18K
Cash Flow Ratios
Operating Cash Flow Per Share
-2.25K -7.96 -18.33 -59.49 -13.90K
Free Cash Flow Per Share
-2.25K -7.96 -18.36 -60.81 -13.94K
CapEx Per Share
<0.01 0.00 0.02 1.32 34.89
Free Cash Flow to Operating Cash Flow
1.00 1.00 1.00 1.02 1.00
Dividend Paid and CapEx Coverage Ratio
-1.62M 0.00 -751.73 -45.01 -398.48
Capital Expenditure Coverage Ratio
-1.62M 0.00 -751.73 -45.01 -398.48
Operating Cash Flow Coverage Ratio
-12.20 -7.69 -7.26 -18.59 -15.25
Operating Cash Flow to Sales Ratio
-1.69 -1.57 -1.52 -1.76 -14.30
Free Cash Flow Yield
-611.33%-244.86%-364.96%-328.02%-5930.44%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
>-0.01 -0.39 -0.25 -0.29 -0.01
Price-to-Sales (P/S) Ratio
0.28 0.64 0.42 0.55 0.24
Price-to-Book (P/B) Ratio
<0.01 0.17 0.21 0.19 0.02
Price-to-Free Cash Flow (P/FCF) Ratio
-0.17 -0.41 -0.27 -0.30 -0.02
Price-to-Operating Cash Flow Ratio
>-0.01 -0.41 -0.27 -0.31 -0.02
Price-to-Earnings Growth (PEG) Ratio
<0.01 <0.01 <0.01 <0.01 >-0.01
Price-to-Fair Value
<0.01 0.17 0.21 0.19 0.02
Enterprise Value Multiple
0.84 1.50 0.52 0.80 0.50
Enterprise Value
-7.36M -10.91M -3.69M -6.25M -6.67M
EV to EBITDA
0.85 1.50 0.52 0.80 0.50
EV to Sales
-1.39 -2.21 -0.80 -1.51 -6.12
EV to Free Cash Flow
0.83 1.40 0.53 0.84 0.43
EV to Operating Cash Flow
0.83 1.40 0.53 0.86 0.43
Tangible Book Value Per Share
-385.79K 16.49 19.48 82.86 8.00K
Shareholders’ Equity Per Share
3.33K 18.75 24.16 98.75 10.43K
Tax and Other Ratios
Effective Tax Rate
0.00 0.00 >-0.01 >-0.01 0.00
Revenue Per Share
1.34K 5.06 12.07 33.78 971.84
Net Income Per Share
-2.29K -8.36 -20.14 -64.92 -16.59K
Tax Burden
1.00 1.00 1.00 1.00 1.00
Interest Burden
0.98 1.05 1.00 0.95 1.35
Research & Development to Revenue
0.48 0.58 0.70 0.90 6.68
SG&A to Revenue
1.52 1.33 1.26 1.41 6.30
Stock-Based Compensation to Revenue
8.62 0.02 0.03 0.07 0.64
Income Quality
<0.01 0.95 0.91 0.92 0.84
Currency in CAD